laquinimod

negative elongation factor complex member C/D, Th1l ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24363970 Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis. 2013 Nov 1
2 22479444 Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. 2012 1